{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:37:16Z","timestamp":1769017036091,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18ek0510023h0002"],"award-info":[{"award-number":["18ek0510023h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1038\/s41409-019-0461-0","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T17:03:59Z","timestamp":1549299839000},"page":"1489-1498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia"],"prefix":"10.1038","volume":"54","author":[{"given":"Yasuhiro","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-7007","authenticated-orcid":false,"given":"Daisuke","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Taga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6508-5496","authenticated-orcid":false,"given":"Hiromasa","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0793-815X","authenticated-orcid":false,"given":"Yozo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyoshi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Ikegame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"461_CR1","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","volume":"28","author":"M Duval","year":"2010","unstructured":"Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol. 2010;28:3730\u20138.","journal-title":"J Clin Oncol"},{"key":"461_CR2","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1200\/JCO.2008.16.4442","volume":"26","author":"NJ Bunin","year":"2008","unstructured":"Bunin NJ, Davies SM, Aplenc R, Camitta BM, DeSantes KB, Goyal RK, et al. Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. J Clin Oncol. 2008;26:4326\u201332.","journal-title":"J Clin Oncol"},{"key":"461_CR3","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1200\/JCO.2000.18.9.1856","volume":"18","author":"KT Godder","year":"2000","unstructured":"Godder KT, Hazlett LJ, Abhyankar SH, Chiang KY, Christiansen NP, Bridges KD, et al. Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: Younger donors and absence of peripheral blasts improve outcome. J Clin Oncol. 2000;18:1856\u201366.","journal-title":"J Clin Oncol"},{"key":"461_CR4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/sj.bmt.1702373","volume":"25","author":"FD Goldman","year":"2000","unstructured":"Goldman FD, Rumelhart SL, DeAlacron P, Holida MD, Lee NF, Miller J, et al. Poor outcome in children with refractory\/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors. Bone Marrow Transplant. 2000;25:943\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"461_CR5","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/sj.bmt.1702690","volume":"26","author":"M Michallet","year":"2000","unstructured":"Michallet M, Thomas X, Vernant JP, Kuentz M, Soci\u00e9 G, Esp\u00e9rou-Bourdeau H, et al. Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: A retrospective study of 379 patients reported to the Soci\u00e8t\u00e8 Francaise de Greffe de Moelle (SFGM). Bone Marrow Transplant. 2000;26:1157\u201363.","journal-title":"Bone Marrow Transplant"},{"key":"461_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/sj.bmt.1704689","volume":"34","author":"ER Nemecek","year":"2004","unstructured":"Nemecek ER, Gooley TA, Woolfrey AE, Carpenter PA, Matthews DC, Sanders JE. Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia. Bone Marrow Transplant. 2004;34:799\u2013806.","journal-title":"Bone Marrow Transplant"},{"key":"461_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/bjh.13611","volume":"171","author":"P Quarello","year":"2015","unstructured":"Quarello P, Fagioli F, Basso G, Maude SL, Fitzgerald JC, Fisher BT, et al. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002\/01 clinical trial. Br J Haematol. 2015;171:566\u201373.","journal-title":"Br J Haematol"},{"key":"461_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.bbmt.2015.11.010","volume":"22","author":"SR Jaiswal","year":"2016","unstructured":"Jaiswal SR, Chakrabarti A, Chatterjee S, Bhargava S, Ray K, O\u2019Donnell P, et al. Haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in children with advanced acute leukemia with fludarabine-, busulfan-, and melphalan-based conditioning. Biol Blood Marrow Transplant. 2016;22:499\u2013504.","journal-title":"Biol Blood Marrow Transplant"},{"key":"461_CR9","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.bbmt.2016.07.016","volume":"22","author":"SR Jaiswal","year":"2016","unstructured":"Jaiswal SR, Zaman S, Chakrabarti A, Sen S, Mukherjee S, Bhargava S, et al. Improved outcome of refractory\/relapsed acute myeloid leukemia after post-transplantation cyclophosphamide-based haploidentical transplantation with myeloablative conditioning and early prophylactic granulocyte colony-stimulating factor-mobilized donor lymphocyte infusions. Biol Blood Marrow Transplant. 2016;22:1867\u201373.","journal-title":"Biol Blood Marrow Transplant"},{"key":"461_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/bmt.2017.3","volume":"52","author":"P O\u2019Hare","year":"2017","unstructured":"O\u2019Hare P, Lucchini G, Cummins M, Veys P, Potter M, Lawson S, et al. Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience. Bone Marrow Transplant. 2017;52:825\u201331.","journal-title":"Bone Marrow Transplant"},{"key":"461_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","volume":"103","author":"Y Atsuta","year":"2016","unstructured":"Atsuta Y. Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol. 2016;103:3\u201310.","journal-title":"Int J Hematol"},{"key":"461_CR12","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","volume":"96","author":"ML Slovak","year":"2000","unstructured":"Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study. Blood. 2000;96:4075\u201383.","journal-title":"Blood"},{"key":"461_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15:367\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"461_CR14","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628\u201333.","journal-title":"Biol Blood Marrow Transplant"},{"key":"461_CR15","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"461_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man: a long term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204\u201317.","journal-title":"Am J Med"},{"key":"461_CR17","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bbmt.2008.04.003","volume":"14","author":"D Weisdorf","year":"2008","unstructured":"Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C, et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant. 2008;14:748\u201358.","journal-title":"Biol Blood Marrow Transplant"},{"key":"461_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"461_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbmt.2004.10.008","volume":"11","author":"R Wong","year":"2005","unstructured":"Wong R, Shahjahan M, Wang X, Thall PF, De Lima M, Khouri I, et al. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. Biol Blood Marrow Transplant. 2005;11:108\u201314.","journal-title":"Biol Blood Marrow Transplant"},{"key":"461_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/sj.bmt.1705011","volume":"36","author":"C Hosing","year":"2005","unstructured":"Hosing C, Saliba RM, Shahjahan M, Estey EH, Couriel D, Giralt S, et al. Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia. Bone Marrow Transplant. 2005;36:157\u201362.","journal-title":"Bone Marrow Transplant"},{"key":"461_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/sj.bmt.1705207","volume":"37","author":"AA Oyekunle","year":"2006","unstructured":"Oyekunle AA, Kr\u00f6ger N, Zabelina T, Ayuk F, Schieder H, Renges H, et al. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. Bone Marrow Transplant. 2006;37:45\u201350.","journal-title":"Bone Marrow Transplant"},{"key":"461_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/ejh.12522","volume":"95","author":"PG Hemmati","year":"2015","unstructured":"Hemmati PG, Terwey TH, Na IK, Jehn CF, le Coutre P, Vuong LG, et al. Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome. Eur J Haematol. 2015;95:498\u2013506.","journal-title":"Eur J Haematol"},{"key":"461_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","volume":"127","author":"C Kollman","year":"2016","unstructured":"Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, et al. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood. 2016;127:260\u20137.","journal-title":"Blood"},{"key":"461_CR24","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1111\/j.1600-6143.2008.02374.x","volume":"8","author":"M Stern","year":"2008","unstructured":"Stern M, Brand R, de Witte T, Sureda A, Rocha V, Passweg J, et al. Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. Am J Transplant. 2008;8:2149\u201357.","journal-title":"Am J Transplant"},{"key":"461_CR25","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1002\/cncr.24531","volume":"115","author":"A Gratwohl","year":"2009","unstructured":"Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T, et al. European Group for Blood and Marrow Transplantation and the European Leukemia Net. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer. 2009;115:4715\u201326.","journal-title":"Cancer"},{"key":"461_CR26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/bmt.2011.110","volume":"47","author":"A Gratwohl","year":"2012","unstructured":"Gratwohl A. The EBMT risk score. Bone Marrow Transplant. 2012;47:749\u201356.","journal-title":"Bone Marrow Transplant"},{"key":"461_CR27","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/leu.2011.13","volume":"25","author":"C Craddock","year":"2011","unstructured":"Craddock C, Labopin M, Pillai S, Finke J, Bunjes D, Greinix H, et al. Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia. Leukemia. 2011;25:808\u201313.","journal-title":"Leukemia"},{"key":"461_CR28","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1182\/blood-2016-07-730564","volume":"128","author":"A Mancusi","year":"2016","unstructured":"Mancusi A, Ruggeri L, Velardi A. Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. Blood. 2016;128:2616\u201323.","journal-title":"Blood"},{"issue":"1","key":"461_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41409-018-0221-6","volume":"54","author":"Motohiro Kato","year":"2018","unstructured":"Kato M, Kurata M, Kanda J, Kato K, Tomizawa D, Kudo K, et al. Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia. Bone Marrow Transplant. \n                    https:\/\/doi.org\/10.1038\/s41409-018-0221-6\n                    \n                  .","journal-title":"Bone Marrow Transplantation"},{"key":"461_CR30","first-page":"3662","volume":"93","author":"F Locatelli","year":"1999","unstructured":"Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia: Eurocord-Cord Blood Transplant Group. Blood. 1999;93:3662\u201371.","journal-title":"Blood"},{"key":"461_CR31","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1182\/blood-2003-04-1288","volume":"102","author":"G Michel","year":"2003","unstructured":"Michel G, Rocha V, Chevret S, Arcese W, Chan KW, Filipovich A, et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood. 2003;102:4290\u20137.","journal-title":"Blood"},{"key":"461_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/bmt.2009.93","volume":"45","author":"K Isoyama","year":"2010","unstructured":"Isoyama K, Oda M, Kato K, Isoyama K, Oda M, Kato K, et al. Long-term outcome of cord blood transplantation from unrelated donors as an initial transplantation procedure for children with AML in Japan. Bone Marrow Transplant. 2010;45:69\u201377.","journal-title":"Bone Marrow Transplant"},{"key":"461_CR33","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","volume":"369","author":"M Eapen","year":"2007","unstructured":"Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369:1947\u201354.","journal-title":"Lancet"},{"key":"461_CR34","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.bbmt.2006.06.003","volume":"12","author":"EP Alyea","year":"2006","unstructured":"Alyea EP, Kim HT, Ho V, Cutler C, DeAngelo DJ, Stone R, et al. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant. 2006;12:1047\u201355.","journal-title":"Biol Blood Marrow Transplant"},{"key":"461_CR35","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1182\/blood-2013-10-535716","volume":"123","author":"M Bitan","year":"2014","unstructured":"Bitan M, He W, Zhang MJ, Abdel-Azim H, Ayas MF, Bielorai B, et al. Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens. Blood. 2014;123:1615\u201320.","journal-title":"Blood"},{"key":"461_CR36","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3324\/haematol.2009.013920","volume":"95","author":"C Craddock","year":"2010","unstructured":"Craddock C, Nagra S, Peniket A, Brookes C, Buckley L, Nikolousis E, et al. Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica. 2010;95:989\u201395.","journal-title":"Haematologica"},{"key":"461_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1182\/blood-2007-08-104745","volume":"112","author":"R Marks","year":"2008","unstructured":"Marks R, Potthoff K, Hahn J, Marks R, Potthoff K, Hahn J, et al. Reduced toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: Particular activity against advanced hematologic malignancies. Blood. 2008;112:415\u201325.","journal-title":"Blood"},{"key":"461_CR38","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/blood-2005-10-4165","volume":"108","author":"C Schmid","year":"2006","unstructured":"Schmid C, Schleuning M, Schwerdtfeger R, Hertenstein B, Mischak-Weissinger E, Bunjes D, et al. Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood. 2006;108:1092\u20139.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0461-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:04Z","timestamp":1684617244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0461-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0461-0","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"13 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}